Novo Nordisk, a global pharmaceutical company and a leader in developing treatments for diabetes, obesity and rare diseases, has announced the establishment of a regional distribution centre in the UAE, further reinforcing the country’s position as a global hub for pharmaceutical manufacturing and advanced supply chains.
